Nightingale Health Oyj NGHLF

$1.62 0.00 (—)

Valuation

Market cap
—
Revenue TTM
$0
Net income TTM
$0
PE ratio
—
Forward PE
—
Profit margin
0.00%
Debt to equity
—

Trading

Volume
400
Avg volume
—
Day's range
$1.62 – $1.62
Shares out
—
Stochastic %K
—
Beta
—
Analysts
Strong Buy
Price target
—

Price

Company profile

Nightingale Health Oyj, a health technology company, offers advanced health check that detects disease risks in Finland, the United Kingdom, rest of Europe, the United States, and internationally. The company's Health Check that detects the risks associated with various common chronic diseases from a single blood sample; and Remote Health Check where health check done remotely. It also offers blood analysis, self col...

Show more

Nightingale Health Oyj, a health technology company, offers advanced health check that detects disease risks in Finland, the United Kingdom, rest of Europe, the United States, and internationally. The company's Health Check that detects the risks associated with various common chronic diseases from a single blood sample; and Remote Health Check where health check done remotely. It also offers blood analysis, self collection kits, urine analysis, and biomarkers services. It provides its services to research programs, universities, and healthcare providers. The company has a collaboration with Personalised Health Clinics to incorporate the company's metabolomic blood testing into Personalised Health Clinics' personalized, clinician-led healthcare services. Nightingale Health Oyj was incorporated in 2002 and is headquartered in Helsinki, Finland.

Industry
Health Information Services
Sector
Healthcare
Phone
358 207301810
Website
https://nightingalehealth.com
Address
Mannerheimintie 164a, Helsinki, Finland

Latest news

No headlines yet.